The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.

kConFab Investigators, Alan D. D'Andrea, Geoffrey I. Shapiro, David L. Wiest, Denise C. Connolly, Mary B. Daly, Elizabeth M. Swisher, Peter Bouwman, Jos Jonkers, Judith Balmana, Violeta Serra, Neil Johnson

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalCancer Research
Publication statusPublished - 2 May 2016

Cite this